West Pharma Shareholder Sues Brass Over Post-Pandemic Financials

West Pharmaceutical Services Inc. executives downplayed destocking issues and financial headwinds that led it to exit longstanding customer relationships, prompting a record stock selloff, a shareholder lawsuit said.

Share prices plummeted more than 38% to close at $199.11 on Feb. 13, 2025, the day the injection parts developer released disappointing 2025 earnings and revenue guidance, partly due to its decision not to continue helping develop devices with two major continuous glucose monitoring customers, said the stockholder’s Philadelphia federal court complaint.

It was the steepest single-day slide recorded since 1980, according to Bloomberg data..

The company also said on Feb. ...